Publication and Presentation. (a) Notwithstanding anything to the contrary in this Section 1.11, Institution and Investigator have the right to publish the results of a Study conducted at Institution subject to the terms and conditions of this Section 1.11.
Publication and Presentation. (i) If either party desires to publish or present the results of the Development Program, the publishing / presenting party shall provide the non-publishing / non-presenting party with a copy of the manuscript of the proposed publication or presentation at least [***] prior to such publication or presentation. The non-publishing / non-presenting party shall then review such manuscript or presentation by providing the publishing / presenting party with comments, if any, as soon as possible, but in no event to exceed [***] after receipt of such manuscript or presentation. The publishing / presenting party agrees to delete any information identified by the non-publishing / non-presenting party as its Trade Secrets or Confidential Information.
(ii) In the event the non-publishing / non-presenting party determines that a patent application covering the information contained in the proposed publication or presentation should be filed, the party proposing the publication or presentation shall delay such publication or presentation to allow a reasonable amount of time for such filing to be made.
Publication and Presentation. PRIME RECIPIENT, or its employees or students, may issue publications or give presentations based on the statement(s) of work of the Prime or Subaward, excluding the Confidential Information of SUBRECIPIENT. PRIME RECIPIENT will provide SUBRECIPIENT an opportunity for thirty (30) days prior to the proposed submission of any publication or the delivery of any presentation to review such publication and, if necessary, request PRIME RECIPIENT to delete any reference to SUBRECIPIENT’S Confidential Information. Furthermore, SUBRECIPIENT shall have the right to request a delay in publication or presentation for up to thirty (30) additional days, if necessary, to allow for filing of patents if such publication or presentation contains patentable subject matter. The right of review SUBRECIPIENT has under this Section shall terminate twelve (12) months from completion of the Subaward, except with respect to any review required consistent with Section 2(b). In no event shall any of SUBRECIPIENT’S Confidential Information be included in any publication or presentation without written authorization from SUBRECIPIENT.
Publication and Presentation. VUB reserves the right to publish or publicly present the results of the Agreement either solely or jointly with researchers of Company. Before publishing or publicly presenting, however, VUB agrees to submit copies of any manuscript proposed for publication or public presentation to Company in advance of the presentation or publication date to discuss its contents, and if Company does not ask within (1) month after receipt to defer publication or presentation of the manuscript so that patent applications may be filed or to amend the manuscript in order to protect Confidential Information disclosed by Company to VUB in relation to the performance of this Agreement, VUB may proceed with the publication or presentation. In the event Company asks to defer publication or presentation, VUB shall not publish or otherwise publicly present any of the information contained in the manuscript until such time as a patent application has been filed or the expiration of four (4) months from the date of submission of the manuscript to Company, whichever occurs first. In the event Company asks to amend the publication or presentation, VUB is entitled to immediately publish or present the manuscript in its amended form. If Company intends to make any scientific publications or presentations on the results of this Agreement, such publication or presentation will be authored jointly with VUB researchers and will make reference to VUB and its involved researchers.
Publication and Presentation. (i) If either party desires to publish or present the results of the Development Program, the publishing / presenting party shall provide the non-publishing / non-presenting party a copy of the manuscript of any proposed publication or presentation. The non-publishing / non-presenting party shall then have thirty (30) days to review and comment on the manuscript or presentation, and the publishing / presenting party agrees to delete any information identified by the non-publishing / non-presenting party as its Trade Secrets or Confidential Information.
(ii) In the event the non-publishing / non-presenting party determines that a patent application covering information contained in the proposed publication or presentation should be filed, the party proposing the publication or presentation shall delay such publication or presentation to allow a reasonable amount of time for such filing to be made.
Publication and Presentation. 6.1 LTI acknowledges that a basic objective of research activities performed by Yissum and Yissum Personnel is the generation and dissemination of new knowledge, and the commercialization thereof.
6.2 Yissum acknowledges that a basic objective of sponsorship by LTI of the Research Program is the generation of data and results for LTI's legitimate business interests. Yissum further acknowledges that worldwide patent protection on Inventions may be obtained only if patent applications are filed before Inventions are publicly disclosed, either orally or in written form.
6.3 Before oral or written disclosure of data and results from performance of the Research Program, Yissum Personnel shall submit copies of any proposed presentation or written abstract or manuscript to LTI at least forty-five (45) days in advance of disclosure to a third party. LTI shall respond to Yissum in writing within fifteen (15) days of receipt of said proposed presentation or written publication. LTI may request an additional delay of up to forty-five (45) days in the presentation or submission to perform whatever action LTI deems necessary to protect its legitimate business interests.
6.4 Publication by either party of research performed hereunder shall give proper credit to the other party, unless that party requests that it not be given credit.
6.5 Publications may be co-authored by Yissum Personnel and LTI Personnel consistent with reasonable professional standards for determining authorship.
6.6 LTI reserves the right to co-author oral or written disclosures by Yissum of data and results obtained in performance of the Research Yissum Program toward which the Company has given substantial scientific contribution. [*] =CONFIDENTIAL TREATMENT REQUESTED
6.7 In the event that LTI declines to exercise its option to obtain a license to an Invention under clause 4.2, LTI shall submit copies of any proposed presentation or written abstract or manuscript describing any aspect of the subject Invention to Yissum for Yissum's prior review and approval.
Publication and Presentation. Enumeral shall have no right hereunder to publish or present any of the Merck Information including, without limitation, Study Results, without first providing any such publication or presentation to Merck for prior review and written approval from Merck; and Enumeral shall have no right to prevent publication or presentation by Merck or its Affiliates of the Merck Information including, without limitation, Study Results. In the event of a publication or presentation by Merck or its Affiliates of the Merck Information, including the Study Results, Merck will use reasonable efforts to acknowledge Enumeral in such materials.
Publication and Presentation. Manuscripts to be submitted for review, as well as research findings submitted for presentation at professional meetings, must be reviewed by the Executive Director prior to submission. This is not a scientific review, and is only intended to bring to light any information that might be proprietary or require risk management efforts on the part of the organization so that information and any response can be most effectively managed. Authorship decisions should follow commonly-accepted guidance (e.g., ICJME xxxx://xxx.xxxxx.xxx/recommendations/browse/roles-and-responsibilities/defining-the-role- of-authors-and-contributors.html) and a KPGA investigator should contribute meaningfully and with attribution. Researchers using the Center's core data systems will acknowledge the Center's development and maintenance of those systems in their reports and publications. Sources of financial support for research will be acknowledged in reports and publications of the research unless the funding source requests that acknowledgement not be given. All manuscripts or presentations using KPGA data and/or funds must be reviewed prior to submission.
Publication and Presentation. The Study being conducted under this Agreement is part of the Overall Study. Subject to the restrictions in this Section 10.0, each Investigator may publish in reputable journals or may present at professional conferences Study Results from his/her respective Site, but only after (a) the results of the Overall Study in its entirety have been published by or with the consent of BIND in an abstract or manuscript, or (b) eighteen (18) months after conclusion of the Overall Study at all investigational research sites for the Overall Study, whichever first occurs first.
Publication and Presentation
